Piramal Pharma

BSE: 543635 | NSE: PPLPHARMA | ISIN: INE0DK501011 | SECTOR: Biotechnology & Drugs

151.10

8.00 (5.59%)
03 May 2024, 03:45 PM IST

Key Metrics

Influencer Count

-

Simple Moving Averages

DaysBSENSE

5143.94144.02
10142.38142.42
20139.59139.62
50132.58132.60
100134.63134.64
300119.00119.02

News

Company Description

Piramal Pharma Limited is an India-based pharmaceutical company, which offers a portfolio of differentiated pharma products across a domestic and global distribution network. The Company has approximately 17 global facilities and a global distribution network in over 100 countries. The Company's subsidiaries include Piramal Pharma Solutions (PPS), an integrated contract development and manufacturing organization; Piramal Critical Care (PCC), a complex hospital generics business, and the India consumer healthcare business selling over-the-counter products. PPS offers end-to-end development and manufacturing solutions through a globally integrated network of facilities across the drug life cycle to generic companies. PCC's complex hospital product portfolio includes inhalation anesthetics, intrathecal therapies for spasticity and pain management, injectable pain, anesthetics, injectable anti-infectives, and other therapies.

Company Officers